IL-4 Antibody (YA4709)
(Synonyms: IL4; Interleukin-4; IL-4; B-cell stimulatory factor 1; BSF-1; Binetrakin; Lymphocyte stimulatory factor 1; Pitrakinra; IL-4 nanobody; )IL-4 Antibody (YA4709) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to IL-4.
-
Host:
Mouse
-
Application:
ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in Phosphate-buffered solution.
-
Conjugation:
Non-conjugated
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Applications
| Application |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|
| Dilution Ratio | 1:5000-100000 |
Product Details
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in Phosphate-buffered solution.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
Interleukin-4 (IL-4) is a critical Th2 cytokine that regulates immune responses by promoting differentiation of naive CD4+ T cells into Th2 cells. Mechanistically, IL-4 activates the JAK-STAT6 signaling pathway, leading to transcriptional induction of genes involved in humoral immunity, including IgE class switching in B cells. In disease models, IL-4 contributes to the pathogenesis of allergic inflammation and asthma by inducing eosinophilia, mucus hyperproduction, and alternatively activated macrophages. Compared with related isoforms such as IL-13, IL-4 exhibits unique receptor engagement, preferentially signaling through IL-4Rα paired with the common gamma chain, which defines distinct cellular responses. IL-4 agonists and inhibitors have been applied in experimental research to modulate Th2-skewed immune responses, enabling the study of allergic airway inflammation and potential therapeutic interventions. Experimental blockade of IL-4 reduces IgE production and airway hyperreactivity, confirming its central role in type 2 immunity and providing a framework for targeted immunomodulation in preclinical models. Therefore, IL-4 serves as both a mechanistic marker and a modifiable factor in studies of cytokine-driven inflammation.
-
Subcellular Localization
Secreted
-
Isoforms & Post-Translational Modification
IL-4 has 2 isomers: P05112-1: 17492 Da (predicted); P05112-2: 15797 Da (predicted).
-
Subunit
Interacts with IL4R. Interacts with IL13RA1
-
SwissProt ID
-
Synonyms
IL4; Interleukin-4; IL-4; B-cell stimulatory factor 1; BSF-1; Binetrakin; Lymphocyte stimulatory factor 1; Pitrakinra; IL-4 nanobody;
Documentation
References
[1]. Nelms K, et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701-38. [Content Brief]
[2]. LaPorte SL,et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008 Jan 25;132(2):259-72 [Content Brief]
[3]. Seyfizadeh N, et al. Interleukin-13 as an important cytokine: A review on its roles in some human diseases. Acta Microbiol Immunol Hung. 2015 Dec;62(4):341-78. [Content Brief]
Powered by Bioz
